
India Approves First Dengue Vaccine QDENGA
The story in brief
India has approved Takeda's QDENGA as its first dengue vaccine, offering a major step in combating the disease, which is emerging as a major seasonal public health threat. The vaccine, which does not require prior blood testing for dengue infection, is designed to protect against all four dengue virus serotypes and has been approved in over 40 countries. However, it may not be immediately available in all hospitals and clinics in India.